Cortisol controlled release by mesoporous silica

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 5, Issue 2, 2009, Pages 170-177

  Lopez, Tessy ^a,b   Ortiz, Emma ^b   Alexander Katz, Roberto ^c   Basaldella, Elena ^d   Bokhimi, Xim ^e  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c DEPARTAMENTO DE QUÍMICA   (Mexico)

^d DEPARTAMENTO DE QUÍMICA   (Argentina)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Drug release; Hydrocortisone; Mesoporous; Ordered silicas; Sol gel

Indexed keywords

CONTROLLED RELEASE; DRUG RELEASE; DRUG RELEASE KINETICS; HYDROCORTISONE; MACROPORES; MESOPOROUS; MESOPOROUS SILICA; ORDERED SILICAS; PLURONICS; RELEASE KINETICS; SODIUM IODIDES; TRIMETHYLBENZENE; TWO STAGE;

ADDITIVES; CAPILLARY FLOW; FUNCTIONAL GROUPS; GELATION; GELS; SILICA; SODIUM; SOL-GEL PROCESS; SOL-GELS; SOLS;

CONTROLLED DRUG DELIVERY;

1,3,5 TRIMETHYLBENZENE; HYDROCORTISONE SODIUM SUCCINATE; NANOTUBE; PLURONIC P123; POLOXAMER; SILICON DIOXIDE; SODIUM IODIDE; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DIFFUSION; NANOPORE;

DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HYDROCORTISONE; KINETICS; PARTICLE SIZE; POROSITY; SILICON DIOXIDE; SPECTROPHOTOMETRY, ULTRAVIOLET; SURFACE PROPERTIES;

EID: 67349238661     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2008.08.002     Document Type: Article

References (30)

1. Benoit J.-P., Faisant N., Verniere-Julienne M.-C., and Menei P. Developments of microspheres for neurological disorders: from basics to clinical applications. J Control Release 65 (2000) 285-296
2. Siepmann J., Faisant N., Akiki J., Richard J., and Benoit J.P. Effect of the size of biodegradable microparticles on drug release: experiment and theory. J Control Release 96 (2004) 123-134
3. Tatard V.M., Venier-Julienne M.C., Saulnier P., Prechter E., Benoit J.P., Menei P., et al. Pharmacologically active microcarriers: a tool for cell therapy. Biomaterials 26 (2005) 3727-3737
4. Elkharraz K., Faisant N., Guse C., Siepmann F., Arica-Yegin B., Oger J.M., et al. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. Int J Pharm 314 (2006) 127-136
5. Koennings S., Garcion E., Faisant N., Menei P., Benoit J.P., and Goepferich A. In vitro investigation of lipid implants as a controlled release system for interleukin-18. Int J Pharm 314 (2006) 145-152
6. Olivier J.-C. Drug transport to brain with targeted nanoparticle. NeuroRX 2 (2005) 108-119
7. Mannila A., Rautio J., Lehtonen M., Järvinen T., and Savolainen J. Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases. Eur J Pharm Sci 24 (2005) 101-105
8. Shaffer C. Nanomedicine transforms drug delivery. Drug Discov Today 10 (2005) 1581-1582
9. Popovic N., and Brundin P. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int J Pharm 314 (2006) 120-126
10. Calabria A.R., and Shusta E.V. Blood-brain barrier genomics and proteomics: elucidating phenotype, identifying disease targets and enabling brain drug delivery. Drug Discov Today 11 (2006) 792-799
11. Rösler A., Vandermeulen G.W.M., and Klok H.-A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev 53 (2001) 95-108
12. Adams M.L., Lavasanifar A., and Kwon G.S. Amphiphilic block copolymers for drug delivery. J Pharm Sci 92 (2003) 1343-1355
13. López T., Ortiz E., Quintana P., and González R.D. Nanostructured titania bioceramic implantable device capable of drug delivery to the temporal lobe of the brain. Colloids Surf A Physicochem Eng Aspects 300 (2007) 3-10
14. Lopez T., Quintana P., Ascencio J., and Gonzalez R.D. The determination of dielectric constants of mixtures used in the treatment of epilepsy and the encapsulation of phenytoin in a titania matrix. Colloids Surf A Physicochem Eng Aspects 300 (2007) 99-105
15. Lopez T., Ortiz-Islas E., Manjarrez J., Rodriguez Reinoso F., Sepulveda A., and Gonzalez R.D. Biocompatible titania microtubes formed by nanoparticles and its application in the drug delivery of valproic acid. Optical Mater 29 (2006) 70-74
16. Lopez T., Manjares J., Rembao D., Vinogradova E., Moreno A., and Gonzalez R.D. An implantable sol-gel derived titania-silica carrier system for the controlled release of anticonvulsants. Mater Lett 60 (2006) 2903-2908
17. Lopez T., Quintana P., Ortiz-Islas E., Vinogradova E., Manjarrez J., Aguilar D.H., et al. Characterization of sodium phenytoin cogelled with titania to be used as controlled drug release system. Mater Charact 58 (2007) 823-828
18. 2 solids for the treatment of temporal lobe epilepsy. Optical Mater 29 (2006) 75-81
19. 2 nanostructured reservoir with temozolomide: structural evolution of the occluded drug. Optical Mater 29 (2006) 88-94
20. 2 brain biocompatible nanoparticles: GBM treatment using C6 model in Wistar rats. Acta Biomater (2008) [in press] (available online)
21. Lopez T., Krotsch E., Ortiz-Islas E., Alvarez M., Basaldella E., Blanes J.M., and Ordrizola J.A. Release properties and acute biosecurity determination of collagen-polyvinylpyrrolidone loaded in ordered mesoporous silica. Key Eng Materials 391 (2009) 169-184. http://www.scientific.net (Available online at www.scientific.net
22. Vallet-Regi M., Rámila A., del Real R.P., and Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater 13 (2001) 308-311
23. Doadrio A.L., Sousa E.M.B., Doadrio J.C., Pérez-Pariente J., Izquierdo-Barba I., and Vallet-Regi M. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J Control Release 97 (2004) 125-132
24. Tamargo R.J., Leong K.W., and Brem H. Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J Neuro-Oncol 9 (1990) 131-138
25. Zhao D., Feng J., Huo Q., Melosh N., Fredrickson G.H., Chmelka B.F., et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279 (1998) 548-552
26. Floström K., Alfredsson V., and Källrot N. Formation of a new Ia3d cubic meso-structured silica via triblock copolymer-assisted synthesis. J Am Chem Soc 125 (2003) 4402-4403
27. Janicke M.T., Landry C.C., Christiansen S.C., Britalan S., Stucky G.D., and Chmelka B.F. Low silica MCM-41 composites and mesoporous solids. Chem Mater 11 (1999) 1342-1351
28. van Grieken R., Calleja G., Stucky G.D., Melero J.A., García R.A., and Iglesias J. Supercritical fluid extraction of a nonionic surfactant template from SBA-15 materials and consequences on the porous structure. Langmuir 19 (2003) 3966-3973
29. Leontidis E. Hofmeister anion effects on surfactant self-assembly and the formation of mesoporous solids. Curr Opin Colloid Interface Sci 7 (2002) 81-91
30. Bagshaw S.A. The effect of dilute electrolytes on the formation of non-ionically templated [Si]-MSU-X mesoporous silica molecular sieves. J Mater Chem 11 (2001) 831-840